论文部分内容阅读
于2015年6月到2016年6月间,在我院选择行术中输血的76例患者,分为非糖尿病组(n=38例)和糖尿病组(n=38例),结果:(1)关于血糖浓度,糖尿病组术前(7.23±1.08)mmol/L、(8.92±1.35)mmol/L、(12.95±1.77)mmol/L均显著高于非糖尿病组(4.38±1.19)mmol/L、(6.32±1.57)mmol/L、(8.44±1.84)mmol/L(P<0.05);(2)糖尿病组高血压发生率76.32%、冠心病发生率63.16%、糖尿病肾病发生率50.00%、视网膜病变发生率28.95%均显著高于非糖尿病组21.05%、15.79%、10.53%、5.26%(P<0.05)。结论:术中输血会使糖尿病患者血糖浓度大幅度上升。
Between June 2015 and June 2016, 76 patients who underwent intraoperative transfusions in our hospital were divided into non-diabetic group (n = 38) and diabetic group (n = 38). Results: (7.23 ± 1.08 mmol / L, (8.92 ± 1.35) mmol / L, (12.95 ± 1.77) mmol / L, respectively) in diabetic group were significantly higher than those in non-diabetic group (4.38 ± 1.19 mmol / L (6.32 ± 1.57) mmol / L and (8.44 ± 1.84) mmol / L respectively (P <0.05). (2) The incidence of hypertension in diabetic group was 76.32%, the incidence of coronary heart disease was 63.16%, the incidence of diabetic nephropathy was 50.00% The incidence of retinopathy was 28.95%, which was significantly higher than that of non-diabetic patients (21.05%, 15.79%, 10.53%, 5.26%, P <0.05). Conclusion: Intraoperative blood transfusion will increase blood glucose levels in patients with diabetes mellitus.